Your browser doesn't support javascript.
loading
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Gibson, Amber; Nunez, Cesar; Robusto, Lindsay; Kammerer, Brianna; Garcia, Miriam; Roth, Michael; Sheth, Rachna; Tewari, Priti; Hittle, Aline; Toepfer, Laurie; Torres, Romeo; Short, Nicholas J; Jabbour, Elias; Jain, Nitin; Cuglievan, Branko; McCall, David.
Affiliation
  • Gibson A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX. algibson2@mdanderson.org.
  • Nunez C; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Robusto L; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston TX.
  • Kammerer B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sheth R; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tewari P; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hittle A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Toepfer L; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Torres R; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cuglievan B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • McCall D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Haematologica ; 2024 May 23.
Article in En | MEDLINE | ID: mdl-38779719
ABSTRACT
Not available.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Haematologica Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Haematologica Year: 2024 Document type: Article